Molecular resistance mechanisms of ALK inhibitors and implications for therapeutic management of ALK-rearranged lung cancer patients

Niu, XiaominPerdomo Lara, Sandra JannethBlackhall, Fiona2020-08-052020-08-0520172219-6803https://hdl.handle.net/20.500.12495/3680application/pdfengAttribution-NonCommercial-NoDerivatives 4.0 InternationalMolecular resistance mechanisms of ALK inhibitors and implications for therapeutic management of ALK-rearranged lung cancer patientsArtículo de revistaNeoplasias PulmonaresInvestigación aplicada -- NeoplasiaTerapéutica -- Neoplasiahttps://dx.doi.org/10.21037/tcr.2017.03.22instname:Universidad El Bosquereponame:Repositorio Institucional Universidad El Bosquehttps://repositorio.unbosque.edu.coMolecular resistance mechanisms of ALK inhibitors and implications for therapeutic management of ALK-rearranged lung cancer patientsAcceso abiertohttps://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessAcceso abierto2017-03